Management of Preoperative Anemia.
Study Goal
The researchers aimed to compare the effectiveness of erythropoiesis-stimulating agents and other therapies for managing perioperative anemia.
Results Summary
The study found conflicting evidence on the optimal treatment for perioperative anemia, noting differences among international guidelines and the need for further research. Erythropoiesis-stimulating agents were discussed as a potential therapy, but no definitive conclusions were drawn about their superiority.
Population
Patients with perioperative anemia.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
iron supplementation | decrease | anemia | perioperative period | - | proposed to treat | #1 |
erythropoiesis-stimulating agents | decrease | anemia | perioperative period | - | proposed to treat | #2 |
Anemia is the most common modifiable risk factor for postoperative morbidity and mortality. Early identification and optimal management are key to restore iron stores and ensure its resolution before surgery. Several therapies have been proposed to treat anemia in the perioperative period, such as iron supplementation and erythropoiesis-stimulating agents, though it remains unclear which is the most optimal to improve clinical outcomes. This article summarizes the most updated evidence on perioperative management of anemia and denotes differences among the international guidelines to reflect the conflicting evidence in this field and the need for further research in specific areas.